Teva expands Samsung Bioepis collaboration with ETICOVO, infliximab-abda deal

Teva is expanding its collaboration with Samsung Bioepis through a deal covering ETICOVO and infliximab-abda, with an upfront payment over three years, possible launch and sales milestones, and shared profits.

Detected & updated continuously · Source: Nebula